Canine atopic dermatitis is a chronic, genetically influenced allergic skin disease causing intense itch, secondary infections, and significant impact on quality of life for millions of affected dogs.
Chronic itch is a profoundly welfare-impairing experience. Dogs with poorly controlled atopic dermatitis spend significant portions of each day scratching, rubbing, and chewing — disrupting sleep, social interaction, and normal behavior. Secondary skin infections compound discomfort and require repeated antibiotic treatment. Quality of life studies show that dogs with severe atopic dermatitis score similarly to dogs with cancer on welfare measures. Modern biologics and targeted immunotherapy have transformed treatment outcomes, providing months of itch relief from single injections. Early, effective treatment prevents the secondary damage and behavioral sensitization that make chronic cases harder to manage.